NeoGenomics (United States)
In research, NeoGenomics (United States) stands highest in Medicine (#17,514 of 17,978 worldwide) and Health Sciences (#20,146 of 20,462 worldwide), over all time. Relative to its size it is most specialised in Biochemistry, Genetics and Molecular Biology — Biochemistry, Genetics and Molecular Biology is 6.8× its share of world research.
- World rank, 2022–2025
- #25,000 of 28,054 · #31,068 all time
- Rank in United States
- #3,767 of 4,192
- Research works
- 271 ▲ 147% vs 2013–17
- Citations
- 3k 11.0 per fractional work
- Top-10% rate
- 4.2% record average 16.5%
- Open access
- 31% world 28%
What is NeoGenomics (United States) known for in research?
The fields where it stands highest, over all time, ranked among every institution above the floor in each field.
| Field | World rank | Where that sits | Top-10% rate | Works |
|---|---|---|---|---|
| MedicineField | #17,514 of 17,978 | 7.7% | 134 | |
| Health SciencesDomain | #20,146 of 20,462 | 7.8% | 136 |
Each strip is that field’s whole ranked pool, with the notch where NeoGenomics (United States) sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no world mark, because the world rate differs by field (from about 6% to 21% in this record).
What does NeoGenomics (United States) specialise in?
Where its research is concentrated relative to its size: Biochemistry, Genetics and Molecular Biology takes 6.8× the share of its output that it takes of world research.
- Biochemistry, Genetics and Molecular BiologyField · 33.5 works6.8×
Location quotient, a volume reading rather than an impact one. It surfaces small, lopsided specialities.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Biochemistry, Genetics and Molecular Biology, 6.8×. Every wedge is a field page.
- Biochemistry, Genetics and Molecular Biology 6.8×
- Immunology and Microbiology 3.8×
- Medicine 2.2×
- Neuroscience 1.2×
- Computer Science 0.8×
- Chemistry 0.6×
- Dentistry 0.5×
- Nursing 0.4×
- Engineering 0.2×
- Energy 0.2×
- Decision Sciences 0.2×
- Economics, Econometrics and Finance 0.2×
- Health Professions 0.1×
- Environmental Science 0.1×
- Psychology 0.1×
- Social Sciences 0.1×
- Physics and Astronomy 0.1×
- Mathematics 0.1×
- Agricultural and Biological Sciences 0.1×
- Earth and Planetary Sciences 0.1×
- Arts and Humanities 0.0×
- Business, Management and Accounting 0.0×
Who are the top researchers at NeoGenomics (United States)?
Ranked on the composite score, Donald H. Chace, Qingyan Au and Wanlong Ma lead among researchers whose main affiliation is NeoGenomics (United States).
- 1 Donald H. Chace United States · #267,737 worldwide 191 citations · 16 works
- 2 Qingyan Au United States · #1,339,053 worldwide 16 citations · 18 works
- 3 Wanlong Ma United States · #1,540,042 worldwide 22 citations · 17 works
Which keywords describe research at NeoGenomics (United States)?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Targeted Therapy, Cell-Free DNA, Genomic Instability, Cancer Genomics, Mutational Signatures, Immunotherapy, Gene Expression and Tumor Microenvironment.
- Radiomics
- Hematopoietic Stem Cells
- Protein Microarrays
- High-Throughput Analysis
- Molecular Profiling
- Feature Extraction
- Quantitative Analysis
- PET Imaging
- Rituximab
- Immune Checkpoint Blockade
- Arginine Deprivation
- Clinical Trials
- Precision Medicine
- Tumor Targeting
- Chemotherapy
- Tumor Microenvironment
- Cancer
- Immunotherapy
- Genomic Instability
- Cell-Free DNA
- Targeted Therapy
- Cancer Genomics
- Mutational Signatures
- Gene Expression
- Machine Learning
- Prognostic Factors
- Gene Therapy
- Nanoparticles
- Biomarkers
- Tumor Regression
- Bacterial Therapy
- PD-1 and PD-L1
- Data Analysis
- Metastasis
- Breast Cancer
- Texture Analysis
- Gene Expression Profiling
- Normalization
- Genomic Profiling
- Lymphoma
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Targeted Therapy10▲ 51×4 topics
- Cell-Free DNA8▲ 92×2 topics
- Cancer Genomics8▲ 125×1 topic
- Genomic Instability8▲ 82×2 topics
- Mutational Signatures8▲ 125×1 topic
- Immunotherapy6▲ 9.4×11 topics
- Gene Expression6▲ 11×9 topics
- Cancer6▲ 4.7×17 topics
- Machine Learning6▲ 1.86×7 topics
- Tumor Microenvironment5▲ 13×6 topics
- Prognostic Factors5▲ 12×7 topics
- Chemotherapy4▲ 6.8×11 topics
- Gene Therapy4▲ 25×3 topics
- Tumor Targeting4▲ 24×2 topics
- Nanoparticles4▲ 3.2×5 topics
- Precision Medicine4▲ 8.7×4 topics
- Biomarkers3▲ 5.3×9 topics
- Clinical Trials3▲ 5.3×7 topics
- Tumor Regression3▲ 33×2 topics
- Arginine Deprivation3▲ 90×1 topic
- Bacterial Therapy3▲ 90×1 topic
- Immune Checkpoint Blockade3▲ 28×1 topic
- PD-1 and PD-L13▲ 28×1 topic
- Rituximab3▲ 21×2 topics
- Data Analysis2▲ 9.8×3 topics
- PET Imaging2▲ 16×3 topics
- Metastasis2▲ 7.7×5 topics
- Quantitative Analysis2▲ 13×2 topics
- Breast Cancer2▲ 11×9 topics
- Feature Extraction2▲ 5.4×2 topics
- Texture Analysis2▲ 11×2 topics
- Molecular Profiling2▲ 24×3 topics
- Gene Expression Profiling2▲ 28×2 topics
- High-Throughput Analysis2▲ 61×1 topic
- Normalization2▲ 43×2 topics
- Protein Microarrays2▲ 126×1 topic
- Genomic Profiling2▲ 20×2 topics
- Hematopoietic Stem Cells2▲ 24×3 topics
- Lymphoma2▲ 13×2 topics
- Radiomics2▲ 18×1 topic
Which research topics does NeoGenomics (United States) publish most on?
By volume in 2022–2025: Cancer Genomics and Diagnostics, Cancer Research and Treatments, Cancer Immunotherapy and Biomarkers and Advanced Biosensing Techniques and Applications.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Cancer Genomics and Diagnostics Cancer Research 8 works
- 2 Cancer Research and Treatments Biotechnology 3 works
- 3 Cancer Immunotherapy and Biomarkers Oncology 3 works
- 4 Advanced Biosensing Techniques and Applications Molecular Biology 2 works
- 5 Radiomics and Machine Learning in Medical Imaging Radiology, Nuclear Medicine and Imaging 2 works
- 6 Lymphoma Diagnosis and Treatment Pathology and Forensic Medicine 2 works
- 7 Acute Myeloid Leukemia Research Hematology 2 works
- 8 Acute Lymphoblastic Leukemia research Public Health, Environmental and Occupational Health 1 works
- 9 Lung Cancer Treatments and Mutations Pulmonary and Respiratory Medicine 1 works
- 10 Myeloproliferative Neoplasms: Diagnosis and Treatment Genetics 1 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has NeoGenomics (United States)'s research output changed?
Output in 2018–2022 was 147% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Aliso Viejo
- Soka University of America
- American Association of Critical-Care Nurses
- Ambry Genetics (United States)
- Microsemi (United States)
- Avanir Pharmaceuticals (United States)
- NVision Eye Centers (United States)
- RxSight (United States)
- Inceptus (United States)
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.